Search This Blog

Thursday, July 30, 2026

Nuwellis study supports epoprostenol as safe alternative anticoagulant for pediatric therapy

 

Nuwellis says Frontiers in Pediatrics accepted study supporting epoprostenol as safe alternative anticoagulant for pediatric Aquadex ultrafiltration therapy

  • Study is described as retrospective and single-center in pediatric patients undergoing Aquadex ultrafiltration therapy.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)